Monocyte tissue factor levels in patients with urological tumours: An association between tumour presence and progression

BJU International

Volumn 83, Issue 4, 1999, Pages 476-482

  Lwaleed, B A ^a,c   Francis, J L ^b   Chisholm, M ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b Hemostasis and Thromb Res Unit   (United States)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Benign disease; Monocyte tissue factor; Prognosis; Progression; Urological tumours

Indexed keywords

ESCHERICHIA COLI ENDOTOXIN; PROSTATE SPECIFIC ANTIGEN; THROMBOPLASTIN;

ADULT; AGED; ARTICLE; ASSAY; BLADDER CANCER; BLADDER TUMOR; BLOOD LEVEL; BONE SCINTISCANNING; CANCER STAGING; CELL LEVEL; CHOLECYSTECTOMY; CONTROLLED STUDY; CYSTOSCOPY; FEMALE; HERNIOPLASTY; HUMAN; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROSTATE TUMOR; TUMOR GROWTH;

DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MONOCYTES; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSTATIC NEOPLASMS; THROMBOPLASTIN; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0033052015     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1999.00944.x     Document Type: Article

References (37)

1. 1 Karpatkin S, Pearlstein E. Role of platelets in tumour cell metastases. Ann Intern Med 1981; 95: 363-641
2. 2 Gordon SG, Franks JJ, Lweis BJ. Cancer procoagulant A. A factor X activating procoagulant from malignant tissue. Thromb Res 1975; 6: 127-37
3. 3 Dvorak HF, VanDeWater L, Bitzer AM et al. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumour cells. Cancer Res 1983; 43: 4434-41
4. 4 Rickles FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 1983; 62: 14-31
5. 5 Fisher KL, Gorman CM, Vehar GA, O'Brien DP, Lawn RM. Cloning and expression of human tissue factor cDNA. Thromb Res 1987; 48: 89-99
6. 6 Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal blood vessel wall and in the atherosclerotic plaque. Proc Nalt Acad Sci USA 1989; 86: 2839-43
7. 7 Maynard JR, Dreyer BA, Stemerman MB, Pitlick FA. Tissue factor coagulation activity of cultured human endothelial and smooth muscle cells and fibroblasts. Blood 1977; 50: 387-96
8. 8 Drake TA, Morrissey JH, Edgington TA. Selective cellular expression of tissue factor in human tissues. Implication for disorders of haemostasis and thrombosis. Am J Pathol 1989; 134: 1087-97
9. 9 Nemerson Y, Bach R. Tissue factor revisited. Prog Hemost Thromb 1982; 6: 237-61
10. 10 Nemerson Y. The tissue factor pathway of blood coagulation. Semin Haemostasis 1992; 29: 170-6
11. 11 Rivers RPA, Hathaway WE, Weston WL. The endotoxin induced coagulant activity of human monocytes. Br J Haem 1975; 30: 311-6
12. 12 Edwards RL, Rickles FR, Cronlund M. Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation. J Lab Clin Med 1981; 98: 917-28
13. 13 Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemostasis 1991; 66: 67-79
14. 14 Dasmahapatra KS, Cheung NK, Spillert C, Lazaro E. An assessment of monocytes procoagulant activity in patients with solid tumours. J Surg Res 1987; 43: 158-63
15. 15 Parmar J, Taylor I, Roath OS, Francis JL. Procoagulant activity in whole blood from patients with breast and colorectal cancer. Blood Coag Fibrinol 1990; 1: 127-32
16. 16 Østerud B, Due J Jr. Blood coagulation in patients with benign and malignant tumours before and after surgery. Special reference to thromboplastin generation in monocytes. Scand J Haematol 1984; 32: 258-64
17. 17 Carvalho MG. Monocyte tissue factor in malignancy. PhD Thesis, Southampton University 1995
18. 18 Mostofi FK, Sobin LH, Torloni H. WHO international histological classification of tumours - no. 10. Geneva: World Health Organization 1973
19. 19 Carson SD, Konisberg WH. Cadmium increases tissue factor (coagulation factor III) activity by facilitating its reassociation with lipids. Science 1980; 208: 307-9
20. 20 McKillop JH, Fogelman I. Clinician's guide to nuclear medicine. Benign and Malignant Disease. London: Churchill Livingstone, 1991: 2-9
21. 21 Hogg N. Human monocytes are associated with the formation of fibrin. J Exp Med 1983; 157: 473-85
22. 22 Edwards RL, Levine JB, Green R et al. Activation of blood coagulation in Crohn's disease: Increased fibrinopeptide A levels and enhanced generation of monocytes tissue factor activity. Gastroenterol 1987; 92: 329-37
23. 23 Contrino J, Hair G, Kreutzer D, Rickles FR. In situ detection of expression of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast tissue. Nature Med 1996; 2: 209-15
24. 24 Østerud B, Olsen JO, Wilsgard L. The role of arachidonic acid release and lipoxygenase pathway in lipopolysaccharide-induced thromboplastin activity in monocytes. Blood Coagul Fibrinol 1990; 1: 41-6
25. 25 Sharfi ARA, El-Sir S, Beleil O. Squamous cell carcinoma of the urinary bladder. Br J Urol 1992; 69: 369-71
26. 26 Amirkhosravi A, Alexander M, Warnes G et al. The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay. Thromb Haemost 1996; 75: 87-95
27. 27 Nemerson Y, Gentry R. An ordered addition, essential activation of model of the tissue factor pathway of coagulation: Evidence for conformational change. Biochemistry 1986; 25: 4020-33
28. 28 Francis JL. Haemostasis and cancer. Med Lab Sci 1989; 46: 331-46
29. 29 Vassali JD, Dayer JM, Wohlwend A, Belin D. Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes macrophages. J Exp Med 1984; 159: 1653-68
30. 30 Old LS. Tumour necrosis factor (TNF). Science 1985; 230: 630-2
31. 31 Dinarello CA. Interleukin-1. Rev Infect Dis 1984; 6: 51-4
32. 32 Rana SV, Reamers HJ, Pathikonda MS, Bajaj SP. Expression of tissue factor and factor VIIa-tissue factor inhibitory activity in endotoxin phorbol ester stimulated U937 monocyte-like cells. Blood 1988; 71: 259-62
33. 33 Naschitz JE, Yeshurun D, Eldar S, Lev LM. Diagnosis of cancer-associated vascular disorders. Cancer 1996; 77: 1759-67
34. 34 Kakkar AK, Lemoine NR, Scully MF, Tebbutt S, Williamson RC. Tissue factor expression correlates with histological grade in human pancreatic cancer. Br J Surg 1995; 82: 1101-4
35. 35 Adamson AS, Francis JL, Roath OS, Witherow RON, Snell ME. Urinary tissue factor levels in transitional cell carcinoma of the bladder. J Urol 1992; 148: 449-52
36. 36 Mufti GR, Singh M. Value of random mucosal biopsies in the management of superficial bladder cancer. Eur Urol 1992; 22: 288-93
37. 37 Adamson AS, Francis JL, Witherow RON, Snell ME. Urinary tissue factor levels in prostatic carcinoma: A potential marker of metastatic spread. Br J Urol 1993; 71: 587-92